Ready to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological genetic diseases? AveXis is advancing cutting-edge science, starting with our proprietary gene therapy for the treatment of spinal muscular atrophy (SMA). We are in the midst of an incredible journey and are looking for passionate individuals to join us on this important mission.
AveXis, a Novartis company, is dedicated to developing and commercializing novel treatments for patients suffering from rare and life-threatening neurological genetic diseases. Our initial product is a proprietary gene therapy approved by the US Food and Drug Administration for the treatment of pediatric patients with SMA. In addition to developing a treatment for SMA, AveXis also plans to develop other novel treatments for rare neurological diseases, including Rett syndrome and a genetic form of amyotrophic lateral sclerosis caused by mutations in the superoxide dismutase 1 (SOD1) gene.
Part of the corporate communications team, our communications manager will be primarily internal communications-focused, including broad-based employee communications, executive communications and support of U.S. site communications, but would also support corporate reputation efforts including digital/social media, branding and corporate media. Operating in a fast-paced environment, our ideal candidate would be comfortable with variety, urgency and shifting priorities, and have extensive healthcare communications experience in an agency or in-house setting.